Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ENDOBARRIER® vs Conventional Therapy in the Management of Metabolic Syndrome in Obese Patients. Medico-economic Analysis as Part of a Randomized Controlled Multicenter Trial - ENDOMETAB

NCT02297555 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT02297555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02297555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ENDOBARRIER® vs Conventional Therapy in the Management of Metabolic Syndrome in Obese Patients. Medico-economic Analysis as Part of a Randomized Controlled Multicenter Trial - ENDOMETAB
Lead sponsor
University Hospital, Lille
Phase
Not applicable
Overall status
Terminated
Start date
April 30, 2014
Completion date
October 31, 2017
Enrollment
82 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome